Triazolopyrimidine derivatives as adp p2y12 receptor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 7/02 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2668182

The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof, wherein X1, X2, R1 R2, R3 and R4 are as defined herein, and their methods of preparation and use as ADP inhibitors.

La présente invention concerne de nouveaux composés bicycliques de la triazolopyrimidine représentés par la formule (I) ou l'une de ses formes. Dans cette formule, X1, X2, R1 R2, R3 et R4 sont tels que définis dans la description. L'invention concerne également les procédés d'élaboration correspondants et leur utilisation comme inhibiteur de l'adénosine 5'-diphosphate (ADP).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Triazolopyrimidine derivatives as adp p2y12 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolopyrimidine derivatives as adp p2y12 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrimidine derivatives as adp p2y12 receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1532696

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.